We are live on ! Find out more
IMDZ

Immune Design Corp.
IMDZ

Delisted

IMDZ was delisted on the 1st of April, 2019.

Back to rankings

72 hedge funds and large institutions have $80.3M invested in Immune Design Corp. in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 16

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 76 → 72 (-4)

20% less capital invested

Capital invested by funds: $101M → $80.3M (-$20.6M)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

92% less call options, than puts

Call options by funds: $4K | Put options by funds: $49K

Holders
72
Holders Change
-4
Holders Change %
-5.26%
% of All Funds
1.65%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
29
Reduced
16
Closed
14
Calls
$4K
Puts
$49K
Net Calls
-$45K
Net Calls Change
-$202K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$9.33M
2
EC
EcoR1 Capital
California
+$3.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$773K
4
TI
Telemetry Investments
New York
+$742K
5
SCM
Stonepine Capital Management
Oregon
+$571K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$12.6M
2
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$5.79M
3
MWNA
Marshall Wace North America
New York
-$1.18M
4
ACP
Acuta Capital Partners
California
-$1.07M
5
Victory Capital Management
Victory Capital Management
Texas
-$613K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$409K +$7.1K +2,005 +2%
TCIM
27
TIAA CREF Investment Management
New York
$273K +$69K +19,484 +31%
WMSA
28
Weiss Multi-Strategy Advisers
New York
$264K -$315K -89,034 -53%
Morgan Stanley
29
Morgan Stanley
New York
$239K +$23.4K +6,600 +10%
TA
30
Teachers Advisors
New York
$217K +$33.5K +9,460 +17%
Balyasny Asset Management
31
Balyasny Asset Management
Illinois
$201K +$41.8K +11,800 +24%
Charles Schwab
32
Charles Schwab
California
$180K – – –
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$170K +$82.9K +23,422 +83%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$167K – – –
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$159K +$171K +48,333 New
Deutsche Bank
36
Deutsche Bank
Germany
$135K -$110K -31,212 -43%
VF
37
Virtu Financial
New York
$125K +$134K +37,772 New
DS
38
DRW Securities
Illinois
$122K +$70.8K +20,000 +118%
T. Rowe Price Associates
39
T. Rowe Price Associates
Maryland
$116K +$219 +62 +0.2%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$85K +$33.5K +9,465 +58%
PCA
41
Personal Capital Advisors
California
$79K – – –
Ameriprise
42
Ameriprise
Minnesota
$73K +$78.3K +22,105 New
AIG
43
American International Group
New York
$68K -$3.9K -1,102 -5%
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$66K – – –
Goldman Sachs
45
Goldman Sachs
New York
$62K +$2.97K +840 +5%
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$61K -$271K -76,559 -81%
Millennium Management
47
Millennium Management
New York
$60K +$64.8K +18,301 New
Group One Trading
48
Group One Trading
Illinois
$58K -$1.77K -500 -3%
Bank of America
49
Bank of America
North Carolina
$46K -$33K -9,331 -40%
VOYA Investment Management
50
VOYA Investment Management
Georgia
$44K – – –
1
2
3 4

IMDZ Hedge Fund Activity: Q1 2018 in Review

72 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q1 2018, worth a combined $80.3M — down 20% from $101M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of IMDZ and 11 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 29 added.

The largest buyer was BVF Inc, adding an estimated $9.33M. The largest seller was Franklin Resources, exiting entirely with an estimated $12.6M sold.

  • 72 institutional investors held Immune Design Corp. (IMDZ) as of Q1 2018, down from 76 in Q4 2017.
  • Funds reported $80.3M of Immune Design Corp. stock for Q1 2018, down 20% quarter-over-quarter.
  • 11 funds opened new Immune Design Corp. positions in Q1 2018 and 14 closed out, a net change of -3 holders.
  • The largest Immune Design Corp. buyer in Q1 2018 was BVF Inc, an estimated $9.33M added.
  • The largest Immune Design Corp. seller in Q1 2018 was Franklin Resources, an estimated $12.6M sold.

Based on aggregated 13F filings for Q1 2018.